Optimi Health Completes MDMA Production Batch to Supply Canadian Phase 3 PTSD Trial ...

Optimi Health Corp. (CSE: OPTI, Nasdaq: OPTH) announced on October 20, 2026, that it has completed a production batch of MDMA finished drug.